Labatec Pharma announces an exclusive licensing agreement signed with AFT Pharmaceuticals, to commercialise MAXIGESIC IV®, in Switzerland
29 März 2023
Would you like to discuss a collaboration or partnership project? Get in touch with us at partnering@labatec.com or connect with us at one of the upcoming events.
Für alle weiteren Anfragen steht Ihnen unsere Kontaktseite zur Verfügung. contact page.